DD209461A5 - Verfahren zur herstellung von 4,5-dihydro-3(2h)-pyridazinonen - Google Patents
Verfahren zur herstellung von 4,5-dihydro-3(2h)-pyridazinonen Download PDFInfo
- Publication number
- DD209461A5 DD209461A5 DD82237856A DD23785682A DD209461A5 DD 209461 A5 DD209461 A5 DD 209461A5 DD 82237856 A DD82237856 A DD 82237856A DD 23785682 A DD23785682 A DD 23785682A DD 209461 A5 DD209461 A5 DD 209461A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- formula
- compound
- group
- acid
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Treating Waste Gases (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH144381 | 1981-03-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD209461A5 true DD209461A5 (de) | 1984-05-09 |
Family
ID=4210578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD82237856A DD209461A5 (de) | 1981-03-04 | 1982-03-03 | Verfahren zur herstellung von 4,5-dihydro-3(2h)-pyridazinonen |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US4613599A (fr) |
| EP (1) | EP0059688B1 (fr) |
| JP (1) | JPS57158762A (fr) |
| AT (1) | ATE13294T1 (fr) |
| AU (1) | AU558039B2 (fr) |
| CA (1) | CA1180703A (fr) |
| CY (1) | CY1396A (fr) |
| DD (1) | DD209461A5 (fr) |
| DE (1) | DE3263497D1 (fr) |
| DK (1) | DK148772C (fr) |
| ES (4) | ES8308561A1 (fr) |
| FI (1) | FI72718C (fr) |
| GB (1) | GB2094302B (fr) |
| GR (1) | GR81397B (fr) |
| HK (1) | HK87687A (fr) |
| HU (1) | HU191083B (fr) |
| IE (1) | IE52672B1 (fr) |
| IL (1) | IL65161A (fr) |
| MY (1) | MY8700736A (fr) |
| NO (1) | NO158135C (fr) |
| NZ (1) | NZ199892A (fr) |
| PT (1) | PT74520B (fr) |
| SG (1) | SG59587G (fr) |
| ZA (1) | ZA821397B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4734415A (en) * | 1982-08-13 | 1988-03-29 | Warner-Lambert Company | Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2H)-pyridazinones and 6-(substituted) phenyl-3(2H)-pyridazinones |
| GB8400863D0 (en) * | 1984-01-13 | 1984-02-15 | Smith Kline French Lab | Chemical compounds |
| GB8426804D0 (en) * | 1984-10-23 | 1984-11-28 | Ciba Geigy Ag | Pyridazinones preparations |
| JPS61158969A (ja) * | 1984-12-24 | 1986-07-18 | ワーナー‐ランバート・コンパニー | 4,5‐ジヒドロ‐4,4‐ジアルキル‐6‐(置換)フエニル‐3(2h)‐ピリダジノン類 |
| IL79280A (en) * | 1985-07-05 | 1990-07-12 | Smith Kline French Lab | 4-(6-oxo-dihydro or tetrahydropyridazin-3-yl)benzene derivatives,their preparation and pharmaceutical compositions containing them |
| US4970210A (en) * | 1987-07-17 | 1990-11-13 | Abbott Laboratories | Triazinone lipoxygenase compounds |
| DE3735207A1 (de) * | 1987-10-17 | 1989-04-27 | Basf Ag | Mittel auf der basis von phenylpyridazinon-derivaten zur wachstumsfoerderung und fettreduktion bei tieren |
| WO2014164704A2 (fr) * | 2013-03-11 | 2014-10-09 | The Broad Institute, Inc. | Composés et compositions utilisables en vue du traitement du cancer |
| JOP20200024A1 (ar) | 2017-08-04 | 2020-02-02 | Bayer Ag | مركبات ثنائي هيدروكساديازينون |
| EP3661917B1 (fr) | 2017-08-04 | 2022-05-11 | Bayer Aktiengesellschaft | Dérivés 6-((3-trifluorométhyl)phényl)-4,5-dihydropyridazin-3(2h)-one en tant qu'inhibiteurs de pde3a et pde3b pour le traitement du cancer |
| AU2020215088A1 (en) | 2019-02-01 | 2021-07-22 | Bayer Aktiengesellschaft | 1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1488330A (en) * | 1923-02-01 | 1924-03-25 | Everitt James | Clothes-hanging bar formed of hinged-together members |
| IL37788A0 (en) * | 1970-10-09 | 1971-12-29 | American Cyanamid Co | New pyridazinone compounds,their preparation and pharmaceutical compositions containing them |
| US3975388A (en) * | 1971-02-22 | 1976-08-17 | Bdh Pharmaceuticals Limited | Pyridazinones |
| GB1383906A (en) * | 1971-02-22 | 1974-02-12 | Bdh Pharmaceuticals Ltd | Pyridazinones |
| GB1488330A (en) * | 1973-12-19 | 1977-10-12 | Smith Kline French Lab | Dihydropyridazinones |
| DE2854191A1 (de) * | 1978-12-15 | 1980-07-03 | Basf Ag | Dihydropyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel |
-
1982
- 1982-02-26 EP EP82810090A patent/EP0059688B1/fr not_active Expired
- 1982-02-26 DE DE8282810090T patent/DE3263497D1/de not_active Expired
- 1982-02-26 FI FI820699A patent/FI72718C/fi not_active IP Right Cessation
- 1982-02-26 AT AT82810090T patent/ATE13294T1/de active
- 1982-03-02 ES ES510055A patent/ES8308561A1/es not_active Expired
- 1982-03-02 CA CA000397433A patent/CA1180703A/fr not_active Expired
- 1982-03-02 GB GB8205989A patent/GB2094302B/en not_active Expired
- 1982-03-02 GR GR67459A patent/GR81397B/el unknown
- 1982-03-02 CY CY139682A patent/CY1396A/en unknown
- 1982-03-03 DK DK91782A patent/DK148772C/da not_active IP Right Cessation
- 1982-03-03 IE IE478/82A patent/IE52672B1/en unknown
- 1982-03-03 DD DD82237856A patent/DD209461A5/de unknown
- 1982-03-03 ZA ZA821397A patent/ZA821397B/xx unknown
- 1982-03-03 HU HU82652A patent/HU191083B/hu unknown
- 1982-03-03 IL IL65161A patent/IL65161A/xx unknown
- 1982-03-03 NZ NZ199892A patent/NZ199892A/en unknown
- 1982-03-03 NO NO820670A patent/NO158135C/no unknown
- 1982-03-03 PT PT74520A patent/PT74520B/pt unknown
- 1982-03-03 AU AU81065/82A patent/AU558039B2/en not_active Ceased
- 1982-03-04 JP JP57033169A patent/JPS57158762A/ja active Pending
-
1983
- 1983-02-23 ES ES520023A patent/ES8403893A1/es not_active Expired
- 1983-02-23 ES ES520022A patent/ES520022A0/es active Granted
- 1983-02-23 ES ES520024A patent/ES8403894A1/es not_active Expired
-
1985
- 1985-07-24 US US06/758,833 patent/US4613599A/en not_active Expired - Fee Related
-
1986
- 1986-05-05 US US06/859,684 patent/US4654340A/en not_active Expired - Fee Related
- 1986-11-28 US US06/935,901 patent/US4704391A/en not_active Expired - Fee Related
-
1987
- 1987-07-22 SG SG595/87A patent/SG59587G/en unknown
- 1987-11-26 HK HK876/87A patent/HK87687A/xx unknown
- 1987-12-30 MY MY736/87A patent/MY8700736A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69128236T2 (de) | N-Acyl-2,3-benzodiazepin-Derivate, diese enthaltende pharmazeutische Zusammensetzungen und Verfahren zu ihrer Herstellung | |
| AU667107B2 (en) | Thiazolylvinylphenyl derivatives | |
| DE2710997C3 (de) | 4-Alkoxy carbonylamino-phenyläthanolamine, deren Herstellung und deren Verwendung als Arzneimittel | |
| DE19638020A1 (de) | Die gastrointestinale Durchblutung fördernde Arzneimittel | |
| EP1778691A1 (fr) | Nouveaux hydrates et polymorphes du 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamide, son procede de production et son utilisation comme medicament | |
| EP0059688B1 (fr) | Pyridazinones, leur procédé de préparation, compositions pharmaceutiques contenant ces composés et leur utilisation | |
| EP0022078B1 (fr) | Pyrazolo-quinoléines, procédés pour leur préparation, et compositions pharmaceutiques les contenant | |
| DE60022986T2 (de) | Pyridazin-3-on-derivate und sie enthaltende Arzneimittel | |
| DE69521125T2 (de) | IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONDERIVATE UND DIESE ENTHALTENDE PHARMAZEUTISCHE ZUBEREITUNGEN | |
| EP0172141B1 (fr) | Pyridazinones substituées, procédé pour leur préparation, compositions pharmaceutiques les contenant et leur application | |
| DE3028001A1 (de) | Neue, in 5-stellung substituierte 5,10-dihydro-11h-dibenzo (b,e)(1,4) diazepin-11-one, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel | |
| DE2424811B2 (de) | Pyrido-benzodiazepinone, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| EP0096279B1 (fr) | N-(2-méthoxyéthyl)-noroxymorphone, ses sels acides d'addition, des médicaments la contenant et un procédé pour sa préparation | |
| EP0085899A2 (fr) | Pyridobenzodiazépinones, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
| DE2215943A1 (de) | Neue 6-Phenyl-4H-s-triazolo eckige Klammer auf 1,5-a eckige Klammer zu eckige Klammer auf 1,4 eckige Klammer zu benzodiazepin-2-carbonsäuren und ihre Ester, sowie Verfahren zu deren Herstellung | |
| DE2040510A1 (de) | Neue Azepin-Derivate | |
| EP0066774A1 (fr) | 1,4,9,10-Tétrahydropyrazolo(4,3-e)pyrido(3,2-b)(1,4)diazépin-10-ones, procédé pour leur préparation et médicaments les contenant | |
| AT390948B (de) | Verfahren zur herstellung von neuen benzamid-derivaten | |
| EP0086981B1 (fr) | Thienobenzodiazépinones substituées, procédé pour leur préparation et médicaments contenant ces composés | |
| EP0085893A2 (fr) | Pyridobenzodiazépinones, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
| DE2609862A1 (de) | Verbindungen mit antidepressiver wirkung | |
| EP0081461A2 (fr) | Imidazobenzodiazépines, procédé pour leur préparation, préparations pharmaceutiques contenant ces composés et leur utilisation thérapeutique | |
| DE2012667A1 (de) | Acyloxyalky!verbindungen, ihre Salze, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| AT256095B (de) | Verfahren zur Herstellung von neuen substituierten α-(3-Indolyl)-säureamiden | |
| DE1670488A1 (de) | Neue 11-Amino-5,6-dihydro-6-morphanthridone |